2026 EXECUTIVE FIELD REPORT

The State of AI in Biotech.

Adoption is real. Operating maturity is scarce. This evidence-backed briefing separates the signal from the theatre and gives leaders a practical path forward.

COMPLIMENTARY EXECUTIVE REPORT

Get the 12-page briefing.

No phone number. No mailing-list trap. Just the report.

HaiPhai will use this information to deliver the report and follow up about your interest. We do not sell contact information. See our privacy notice.

INSIDE THE REPORT

A briefing designed to create a better leadership conversation.

01

Adoption versus maturity

A clear read on why AI use is spreading faster than repeatable, governed operating capability.

02

The regulatory direction

What FDA, EMA, NIST, and the EU are signaling about context, evidence, oversight, and lifecycle control.

03

An executive action system

A maturity model, ten-question scorecard, and practical 90-day agenda leaders can use immediately.

EVIDENCE, NOT THEATRE

Sources are visible. Interpretation is labeled.

The report synthesizes current FDA and EMA materials, a UK government engineering-biology survey, NIST guidance, the EU AI Act, NIH strategy, peer-reviewed literature, and clearly attributed industry surveys.

It includes no invented client results, proprietary benchmarks, or unsupported ROI claims.